Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journalsort descending
Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial Supportive Care in Cancer
Optimizing the synthesis of clinical trial data using sequential trees Journal of the American Medical Informatics Association
Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) National Academies Press
Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients British Journal of Clinical Pharmacology
Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data Journal of Cancer
Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer JAMA Network Open
Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma Journal of the American Academy of Dermatology
Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer Cancer Research
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy Annals of Oncology
Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile Pharmaceutical Statistics
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab Cancer Immunology, Immunotherapy
Can synthetic data be a proxy for real clinical trial data? A validation study BMJ Open
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology
Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer Algorithms

Pages